BETA
BETA
Capricor Therapeutics
CAPR65
$4.37arrow_drop_down1.35%-$0.06
Penny Stock
CAPR65
$4.37
arrow_drop_down1.35%| Key Stats | |
|---|---|
| Open | $4.45 |
| Prev. Close | $4.43 |
| EPS | -0.83 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $139.74M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 4.32 | 4.56 |
| 52 Week Range | 2.68 | 8.22 |
| Ratios | |
|---|---|
| EPS | -0.83 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.86% |
| Last Dividend pay date | Jun 5, 2019 |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
CAPRarrow_drop_down1.35%
US Healthcare Sectorarrow_drop_up0.96%
US Marketarrow_drop_up1.18%
warning
CAPR / Market
CAPR lose to the US Market which returned 1.18% over the last twenty four hours.warning
CAPR / Healthcare Sector
CAPR lose to the US Healthcare sector which returned 0.96% over the last twenty four hours.Capricor Therapeutics (CAPR) Statistics
Keep an eye on Capricor Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Capricor Therapeutics (CAPR) stock's performance compared to its sector and the market over the past year?
Over the past year, Capricor Therapeutics (CAPR) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 24.34%, Capricor Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 52.01%, it has fallen short of the market average. This comparison highlights Capricor Therapeutics 's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Capricor Therapeutics (CAPR) stock?
The PE ratio for Capricor Therapeutics (CAPR) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Capricor Therapeutics (CAPR) stock?
The Earnings Per Share (EPS) for Capricor Therapeutics (CAPR), calculated on a diluted basis, is -$0.83. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Capricor Therapeutics (CAPR) stock?
The operating margin for Capricor Therapeutics (CAPR) is -209.22%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Capricor Therapeutics (CAPR) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Capricor Therapeutics (CAPR) is -$24.99M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Capricor Therapeutics (CAPR) have?
Capricor Therapeutics (CAPR) has a total debt of $2.02M. The net debt, which accounts for cash and cash equivalents against the total debt, is -$817.39K.
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.